Semanext 1 Reusable Customized Pen is a reusable injection device designed to administer Semanext semaglutide injection from a compatible cartridge. Importantly, the pen shown in the image is the delivery device itself and does not contain semaglutide. The medicine is supplied separately in a Semanext cartridge. Lupin and Zydus introduced this reusable pen system in India alongside semaglutide injection for diabetes and chronic weight management.
Semaglutide is a GLP-1 receptor agonist that can be prescribed for chronic weight management in appropriate adults alongside a reduced-calorie diet and increased physical activity.
What Is the Semanext Reusable Pen Used For?
The Semanext reusable pen is designed to deliver compatible Semanext semaglutide injection through subcutaneous injection.
Semanext is a semaglutide injection containing 15 mg in a 3mL solution. Lupin has included a patient-friendly reusable pen device with the medicine.
The drug semaglutide medicine, being promoted by Lupin, is targeted to adult type 2 diabetic patients. It is also related to chronic weight management in the case of an obese/adult overweight person with no fewer than one weight-related health condition when combined dietary calorie intake reduction and more physical activity.
In terms of the product being a reused pen drug, the compatible cartridge can be used with the pen. It does not require a completely new pen device for every cartridge.
How Does Semanext Pen Work?
The pen acts as a mechanical delivery system.
A compatible Semanext semaglutide cartridge is inserted into the reusable pen. The prescribed dose is selected using the pen’s dosing mechanism, and the medicine is then delivered by subcutaneous injection.
Zydus describes the underlying reusable pen technology as an adjustable device that can deliver different approved semaglutide strengths through a single reusable pen.
This is different from a pre-filled disposable pen, where the medicine and injection device are supplied together and the entire pen is discarded after its intended use.
What Medicine Is Used With the Semanext Pen?
The pen is designed specifically for Semanext injection cartridges.
Current product information lists Semanext injection as semaglutide 15mg/3mL (5mg/mL) in a cartridge format. The reusable pen and cartridge are separate components.
The pen should not be assumed to be compatible with other semaglutide cartridges or medicines. Use only the cartridge specified by the manufacturer and prescribed by your healthcare professional.
How to Use the Semanext Reusable Pen
Because this is a reusable medical device, the exact loading, dose-setting and injection procedure should follow the Semanext Instructions for Use supplied with the pen and cartridge.
In general, the process involves:
- Check the pen and compatible cartridge before use.
- Insert the Semanext cartridge according to the manufacturer’s instructions.
- Attach a new compatible disposable needle.
- Select the prescribed semaglutide dose using the pen’s dose mechanism.
- Inject the medicine subcutaneously at the recommended injection site.
- Remove and safely dispose of the used needle.
- Store the reusable pen and remaining cartridge according to their respective instructions.
Do not attempt to modify the pen or use a cartridge that is not specified for the device.
Semaglutide Injection for Weight Management
The pen itself does not cause weight loss. Weight management is associated with the semaglutide medicine delivered through the device.
Semaglutide works through GLP-1 receptors that have a role of controlling your appetite. It makes one feel full faster besides decreasing hunger and the actual food intake.
According to Australian Healthdirect, Wegovy contains semaglutide which is recommended to be taken along with a low-calorie diet and physical activity as a weight management strategy for adult patients who qualify for it.
The Australian indication includes adults with:
- BMI ≥30 kg/m², or
- BMI ≥27 kg/m² and <30 kg/m² with at least one weight-related health condition.
Australian Wegovy information also includes specific weight-management use in certain adolescents aged 12 years and older.
These Australian indications apply to TGA-registered semaglutide products such as Wegovy, not automatically to Semanext.
Semaglutide Dose Escalation
The dose of semaglutide should be increased gradually according to the prescribing doctor’s instructions.
For Australian Wegovy, the established escalation schedule is:
| Treatment period | Weekly dose |
| Weeks 1–4 | 0.25mg |
| Weeks 5–8 | 0.5mg |
| Weeks 9–12 | 1mg |
| Weeks 13–16 | 1.7mg |
| Maintenance | 2.4mg |
This table refers to the Australian Wegovy regimen, not a separate dosing instruction for the Semanext pen. The appropriate Semanext dose must be determined from the prescribed semaglutide regimen and the manufacturer’s instructions for the cartridge/pen.
Do not increase the dose simply because the pen allows different dose settings.
Possible Side Effects of Semaglutide
Because the Semanext pen is only a delivery device, side effects are associated primarily with the semaglutide medicine, rather than the pen itself.
Common effects reported with semaglutide include:
- nausea
- vomiting
- diarrhoea
- constipation
- abdominal pain or discomfort
- indigestion
- bloating
- headache
- dizziness
- tiredness
- injection-site reactions
Gastrointestinal effects are particularly common when treatment is started or the dose is increased.
Important Warning Signs
Seek medical attention if you develop severe or persistent abdominal pain, particularly if it occurs with nausea or vomiting, because semaglutide has been associated with acute pancreatitis.
Persistent vomiting or diarrhoea can also cause dehydration.
Precautions When Using Semanext for Weight Management
Before using semaglutide through the Semanext system, tell your doctor if you have:
- previously had pancreatitis
- gallbladder problems or gallstones
- kidney disease
- liver problems
- significant gastrointestinal disease
- diabetic retinopathy
- diabetes treated with insulin or sulfonylureas
- an allergy to semaglutide
- a planned operation or procedure involving anaesthesia
Semaglutide can delay stomach emptying. The TGA has warned that GLP-1 medicines may increase the risk of aspiration during general anaesthesia or deep sedation. Tell your anaesthetist that you use semaglutide before a procedure.
Pregnancy and Semaglutide
Semaglutide is not recommended for the purpose of weight management during pregnancy.
The Australian product information advises that semaglutide should be stopped at least 2 months before conception as the drug stays in the body for a very long time.
In the situation where you get pregnant while taking semaglutide, you should consult a healthcare professional immediately.
Semanext Pen vs Semaglutide Medicine
It is useful to keep the two components separate:
| Semanext Reusable Pen | Semanext Semaglutide Injection |
| Reusable delivery device | Prescription medicine |
| Does not contain medicine itself | Contains semaglutide |
| Used with compatible cartridge | Provides the active ingredient |
| Can be reused according to IFU | Used according to prescribed dosing schedule |
| Does not cause weight loss by itself | Can be used for chronic weight management in eligible patients |
This distinction is especially important when describing the product online.
How to Store the Semanext Pen
The pen device and semaglutide cartridge have different storage considerations.
The Semanext reusable pen itself is listed by product information as a reusable device, with storage information indicating a temperature not exceeding 30°C.
The semaglutide cartridge, however, requires its own medicine-specific storage conditions. Current Semanext product information states that the semaglutide injection is refrigerated at 2°C–8°C and should not be frozen.
Do not confuse the storage requirements for the empty reusable pen with those for the medicine cartridge.
For Australian semaglutide products, Healthdirect also advises refrigeration at 2°C–8°C, protection from light and avoiding freezing.
Is Semanext Reusable Pen Available in Australia?
Semanext is an Indian product marketed by Lupin, and I could not verify this specific Semanext reusable pen or Semanext semaglutide cartridge as an Australian ARTG-registered product.
Australia does have TGA-registered semaglutide products, including Wegovy. Healthdirect currently lists Wegovy as a Schedule 4 prescription medicine in Australia.
Therefore, the Australian information about Wegovy should be used as active-ingredient/general semaglutide reference information, not as evidence that Semanext itself is TGA-registered.
FAQs
1. Does the Semanext reusable pen come filled with semaglutide?
No. The Semanext reusable pen is a delivery device. The semaglutide medicine is supplied separately in a compatible cartridge.
2. Can the Semanext pen be thrown away after one injection?
No. It is specifically designed as a reusable pen device. It should be retained and reused according to the manufacturer’s instructions, while disposable needles should be replaced after each injection.
3. Can I use any semaglutide cartridge with the Semanext pen?
No. Use only the cartridge specified as compatible with the device. The Semanext pen was designed for Semanext injection cartridges, and using an incompatible cartridge could result in incorrect dosing or device malfunction.
4. Does the Semanext pen need to be refrigerated?
The empty reusable pen does not have the same refrigeration requirement as the semaglutide medicine. Product information indicates storage of the device at temperatures not exceeding 30°C, while the semaglutide cartridge has separate refrigerated storage requirements.
5. Can the Semanext pen be used for different semaglutide doses?
The Semanext reusable system was developed as an adjustable delivery device intended to support different semaglutide dose strengths during treatment. However, the dose should always be selected according to the prescription and the manufacturer’s instructions, rather than adjusted independently.
References
- Lupin — Semanext and Semaglutide Injection: (Lupin)
- Healthdirect Australia — Wegovy: (Healthdirect)
- TGA Australia — Wegovy Product Information: (Therapeutic Goods Administration (TGA))
Medical Disclaimer
Semanext Reusable Customized Pen is a medical delivery device and does not itself contain semaglutide. Weight-management effects come from the compatible semaglutide medicine administered through the device.
Semaglutide is a prescription medicine and should be used only under appropriate medical supervision. Do not change the dose, cartridge or injection schedule without consulting your healthcare professional.
